U-Blot® Research Grade Anti-Human CD184/CXCR4 (LY2624587)Cat. No. WA1348Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD184/CXCR4 (LY2624587)Cat. No. WA1348
U-Blot® Research Grade Anti-Human CD184/CXCR4 (KY1051)Cat. No. WA1347
U-Blot® Research Grade Anti-Human CD184/CXCR4 (CF172)Cat. No. WA1346
U-Blot® Research Grade Anti-Human CD184/CXCR4 (AT009)Cat. No. WA1345
U-Blot® Research Grade Anti-Human CD184/CXCR4 (ALX-0651)Cat. No. WA1344
U-Blot® Research Grade Anti-Human CD18/ITGB2 (YFC51.1)Cat. No. WA1343
U-Blot® Research Grade Anti-Human CD18/ITGB2 (H52)Cat. No. WA1342
U-Blot® Research Grade Anti-Human CD172a/SIRPA Antibody (GS 0189)Cat. No. WA1341
U-Blot® Research Grade Anti-Human CD172a/SIRPA Antibody (BI 765063)Cat. No. WA1340
U-Blot® Research Grade Anti-Human CD172a/SIRPA (OSE-172)Cat. No. WA1339
U-Blot® Research Grade Anti-Human CD172a/SIRPA (ES004)Cat. No. WA1338
U-Blot® Research Grade Anti-Human CD172a/SIRPA (CC-95251)Cat. No. WA1337